Jaguar Health, Inc. – NASDAQ:JAGX
Founder-led company
Jaguar Health stock price today
$2.03
+0.99
+97.09%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 14 hours
Jaguar Health stock price monthly change
-74.69%
month
Jaguar Health stock price quarterly change
-74.69%
quarter
Jaguar Health stock price yearly change
+531.90%
year
Jaguar Health key metrics
Market Cap | 11.31M |
Enterprise value | 30.13M |
P/E | -0.02 |
EV/Sales | 1.72 |
EV/EBITDA | -0.70 |
Price/Sales | 0.04 |
Price/Book | -0.57 |
PEG ratio | N/A |
EPS | -1.52 |
Revenue | 10.14M |
EBITDA | -29.88M |
Income | -38.32M |
Revenue Q/Q | 19.21% |
Revenue Y/Y | -10.28% |
Profit margin | -427.42% |
Oper. margin | -300.81% |
Gross margin | 83.26% |
EBIT margin | -300.81% |
EBITDA margin | -294.74% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeJaguar Health stock price history
Jaguar Health stock forecast
Jaguar Health financial statements
| Jun 2023 | 2.67M | -12.15M | -454.04% |
|---|---|---|---|
| Sep 2023 | 2.81M | -7.77M | -276.5% |
| Dec 2023 | 2.3M | -9.17M | -398.7% |
| Mar 2024 | 2.35M | -9.22M | -392.43% |
| Sep 2025 | 7M | -16.09M | -229.88% |
|---|---|---|---|
| Oct 2025 | 6.3M | -190.61M | -3025.57% |
| Dec 2025 | 8.35M | -3.31M | -39.74% |
| Dec 2025 | 5.9M | -95.30M | -1615.35% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 52172000 | 46.34M | 88.83% |
|---|---|---|---|
| Sep 2023 | 45380000 | 43.96M | 96.88% |
| Dec 2023 | 50763000 | 45.86M | 90.35% |
| Mar 2024 | 55389000 | 41.08M | 74.18% |
| Jun 2023 | -9.05M | 6.27M | 3.35M |
|---|---|---|---|
| Sep 2023 | -6.79M | -20K | 1.40M |
| Dec 2023 | -7.45M | 6K | 10.64M |
| Mar 2024 | -7.04M | 0 | 12.26M |
Jaguar Health alternative data
| Aug 2023 | 60 |
|---|---|
| Sep 2023 | 60 |
| Oct 2023 | 60 |
| Nov 2023 | 60 |
| Dec 2023 | 60 |
| Jan 2024 | 60 |
| Feb 2024 | 60 |
| Mar 2024 | 60 |
| Apr 2024 | 60 |
| May 2024 | 49 |
| Jun 2024 | 49 |
| Jul 2024 | 49 |
Jaguar Health other data
100.00%
+94.56%
of JAGX is owned by hedge funds
180.85K
+103.65K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2022 | 317 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | CHATURVEDI PRAVIN R officer: Chief Scientific Officer | Common Stock | 871 | N/A | N/A | ||
Option | CHATURVEDI PRAVIN R officer: Chief Scientific Officer | Restricted stock units | 871 | N/A | N/A | ||
Option | WOLIN JONATHAN S. officer: Chief of Staff, CCO & GC | Common Stock | 871 | N/A | N/A | ||
Option | WOLIN JONATHAN S. officer: Chief of Staff, CCO & GC | Restricted stock units | 871 | N/A | N/A | ||
Option | LIZAK CAROL R. officer: Chief Financial Officer | Common Stock | 431 | N/A | N/A | ||
Option | CONTE LISA A director, officer.. | Restricted stock units | 2,695 | N/A | N/A | ||
Option | LIZAK CAROL R. officer: Chief Financial Officer | Restricted stock units | 431 | N/A | N/A | ||
Option | KING STEVEN R. officer: See Rema.. | Common Stock | 612 | N/A | N/A | ||
Option | KING STEVEN R. officer: See Rema.. | Restricted stock units | 612 | N/A | N/A | ||
Option | CONTE LISA A director, officer.. | Common Stock | 2,695 | N/A | N/A |
| Quarter | Transcript |
|---|---|
| Q1 2024 14 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 1 Apr 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 14 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 14 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Ms. Lisa A. Conte (1959) Founder, Chief Executive Officer, Pres & Director | $525,210 |
Mr. Jonathan S. Wolin CPA, J.D., M.B.A. (1962) Chief of Staff, Chief Compliance Officer & Gen. Counsel | $336,510 |
| Dr. Steven R. King (1958) Chief Sustainable Supply, Ethnobotanical Research & Intellectual Property and Sec. | $332,230 |
-
What's the price of Jaguar Health stock today?
One share of Jaguar Health stock can currently be purchased for approximately $2.03.
-
When is Jaguar Health's next earnings date?
Unfortunately, Jaguar Health's (JAGX) next earnings date is currently unknown.
-
Does Jaguar Health pay dividends?
No, Jaguar Health does not pay dividends.
-
How much money does Jaguar Health make?
Jaguar Health has a market capitalization of 11.31M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 18.36% to 9.76M US dollars.
-
What is Jaguar Health's stock symbol?
Jaguar Health, Inc. is traded on the NASDAQ under the ticker symbol "JAGX".
-
What is Jaguar Health's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Jaguar Health?
Shares of Jaguar Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Jaguar Health's key executives?
Jaguar Health's management team includes the following people:
- Ms. Lisa A. Conte Founder, Chief Executive Officer, Pres & Director(age: 66, pay: $525,210)
- Mr. Jonathan S. Wolin CPA, J.D., M.B.A. Chief of Staff, Chief Compliance Officer & Gen. Counsel(age: 63, pay: $336,510)
- Dr. Steven R. King Chief Sustainable Supply, Ethnobotanical Research & Intellectual Property and Sec.(age: 67, pay: $332,230)
-
Is Jaguar Health founder-led company?
Yes, Jaguar Health is a company led by its founder Ms. Lisa A. Conte.
-
How many employees does Jaguar Health have?
As Jul 2024, Jaguar Health employs 49 workers, which is 18% less then previous quarter.
-
When Jaguar Health went public?
Jaguar Health, Inc. is publicly traded company for more then 10 years since IPO on 12 May 2015.
-
What is Jaguar Health's official website?
The official website for Jaguar Health is jaguar.health.
-
Where are Jaguar Health's headquarters?
Jaguar Health is headquartered at 200 Pine Street, San Francisco, CA.
-
How can i contact Jaguar Health?
Jaguar Health's mailing address is 200 Pine Street, San Francisco, CA and company can be reached via phone at +41 53718300.
Jaguar Health company profile:
Jaguar Health, Inc.
jaguar.healthExchange:
NASDAQ
Full time employees:
49
Industry:
Biotechnology
Sector:
Healthcare
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer for multiple possible follow-on indications, including cancer therapy-related diarrhea; orphan-drug indications for symptomatic relief of diarrhea in infants and children with congenital diarrheal disorders and for adult and pediatric patients for short bowel syndrome with intestinal failure with; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops lechlemer, a second-generation anti-secretory agent for cholera; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. Jaguar Health, Inc. was founded in 2013 and is headquartered in San Francisco, California.
200 Pine Street
San Francisco, CA 94104
San Francisco, CA 94104
CIK: 0001585608
ISIN: US47010C7065
CUSIP: 47010C607
